Integrated Biopharma, Inc. INBP
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.84M | -1.65M | -206.00K | 672.00K | 808.00K |
| Total Depreciation and Amortization | 1.39M | 1.34M | 1.29M | 1.28M | 1.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 486.00K | 747.00K | 1.16M | 1.36M | 1.49M |
| Change in Net Operating Assets | 2.21M | 2.59M | 883.00K | -596.00K | -1.50M |
| Cash from Operations | 1.24M | 3.03M | 3.13M | 2.71M | 2.07M |
| Capital Expenditure | -346.00K | -187.00K | -303.00K | -308.00K | -191.00K |
| Sale of Property, Plant, and Equipment | 6.00K | 6.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -14.00K | -14.00K | -14.00K | -14.00K |
| Cash from Investing | -340.00K | -195.00K | -317.00K | -322.00K | -205.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -45.00K | -34.00K | -23.00K | -12.00K | -8.00K |
| Issuance of Common Stock | -- | 68.00K | 68.00K | 86.00K | 86.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.00K | 34.00K | 45.00K | 74.00K | 78.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 856.00K | 2.87M | 2.85M | 2.46M | 1.94M |